Prevalence and Healthcare Costs of Metabolic Disorders Among Individuals with Schizophrenia Following Initiation of Oral Antipsychotic Therapy

This analysis demonstrated that new onset of a metabolic disorder following OAP initiation was associated with higher healthcare costs from the perspective of US healthcare payers. Reduction of metabolic disorders may be key in reducing the economic burden of schizophrenia.